Michelle Martin and Sani Hamid, Director for Wealth Management,  Financial Alliance discuss the market reaction to the FDA's emergency approval of the Pfizer/BioNTech vaccine, a bipartisan COVID-19 relief package in the US, ongoing Brexit negotiations,  the high value of the Renminbi, an improvement in Japanese business sentiment and Singapore stocks.

<p>Michelle Martin and Sani Hamid, Director for Wealth Management,&nbsp; Financial Alliance discuss the market reaction to the FDA's emergency approval of the Pfizer/BioNTech vaccine, a bipartisan COVID-19 relief package in the US, ongoing Brexit negotiations,&nbsp; the high value of the Renminbi, an improvement in Japanese business sentiment and Singapore stocks.</p>

Advertisement